id	sid	tid	token	lemma	pos
ffhd-1666	1	1	rice	rice	NOUN
ffhd-1666	1	2	-	-	PUNCT
ffhd-1666	1	3	derived	derive	VERB
ffhd-1666	1	4	glucosylceramides	glucosylceramide	NOUN
ffhd-1666	1	5	up	up	ADP
ffhd-1666	1	6	-	-	PUNCT
ffhd-1666	1	7	regulate	regulate	VERB
ffhd-1666	1	8	hla	hla	PROPN
ffhd-1666	1	9	-	-	PUNCT
ffhd-1666	1	10	dr	dr	NOUN
ffhd-1666	1	11	expression	expression	NOUN
ffhd-1666	1	12	on	on	ADP
ffhd-1666	1	13	myeloid	myeloid	ADJ
ffhd-1666	1	14	dendritic	dendritic	ADJ
ffhd-1666	1	15	cells	cell	NOUN
ffhd-1666	1	16	to	to	PART
ffhd-1666	1	17	activate	activate	VERB
ffhd-1666	1	18	innate	innate	ADJ
ffhd-1666	1	19	immune	immune	ADJ
ffhd-1666	1	20	responses	response	NOUN
ffhd-1666	1	21	in	in	ADP
ffhd-1666	1	22	healthy	healthy	ADJ
ffhd-1666	1	23	japanese	japanese	ADJ
ffhd-1666	1	24	subjects	subject	NOUN
ffhd-1666	1	25	:	:	PUNCT
ffhd-1666	1	26	a	a	DET
ffhd-1666	1	27	randomized	randomized	ADJ
ffhd-1666	1	28	,	,	PUNCT
ffhd-1666	1	29	placebo	placebo	NOUN
ffhd-1666	1	30	-	-	PUNCT
ffhd-1666	1	31	controlled	control	VERB
ffhd-1666	1	32	,	,	PUNCT
ffhd-1666	1	33	double	double	ADJ
ffhd-1666	1	34	-	-	PUNCT
ffhd-1666	1	35	blind	blind	ADJ
ffhd-1666	1	36	trial	trial	NOUN
ffhd-1666	1	37	|	|	ADV
ffhd-1666	1	38	functional	functional	ADJ
ffhd-1666	1	39	foods	food	NOUN
ffhd-1666	1	40	in	in	ADP
ffhd-1666	1	41	health	health	NOUN
ffhd-1666	1	42	and	and	CCONJ
ffhd-1666	1	43	disease	disease	PROPN
ffhd-1666	1	44	online	online	PROPN
ffhd-1666	1	45	issn	issn	PROPN
ffhd-1666	1	46	:	:	PUNCT
ffhd-1666	1	47	2160	2160	NUM
ffhd-1666	1	48	-	-	SYM
ffhd-1666	1	49	3855	3855	NUM
ffhd-1666	1	50	;	;	PUNCT
ffhd-1666	1	51	print	print	NOUN
ffhd-1666	1	52	issn	issn	PROPN
ffhd-1666	1	53	:	:	PUNCT
ffhd-1666	1	54	2378	2378	NUM
ffhd-1666	1	55	-	-	SYM
ffhd-1666	1	56	7007	7007	NUM
ffhd-1666	1	57	skip	skip	NOUN
ffhd-1666	1	58	to	to	ADP
ffhd-1666	1	59	main	main	ADJ
ffhd-1666	1	60	content	content	NOUN
ffhd-1666	1	61	skip	skip	ADJ
ffhd-1666	1	62	to	to	ADP
ffhd-1666	1	63	main	main	ADJ
ffhd-1666	1	64	navigation	navigation	NOUN
ffhd-1666	1	65	menu	menu	NOUN
ffhd-1666	1	66	skip	skip	VERB
ffhd-1666	1	67	to	to	PART
ffhd-1666	1	68	site	site	VERB
ffhd-1666	1	69	footer	footer	ADJ
ffhd-1666	1	70	open	open	ADJ
ffhd-1666	1	71	menu	menu	NOUN
ffhd-1666	1	72	functional	functional	ADJ
ffhd-1666	1	73	foods	food	NOUN
ffhd-1666	1	74	in	in	ADP
ffhd-1666	1	75	health	health	NOUN
ffhd-1666	1	76	and	and	CCONJ
ffhd-1666	1	77	disease	disease	PROPN
ffhd-1666	1	78	online	online	PROPN
ffhd-1666	1	79	issn	issn	PROPN
ffhd-1666	1	80	:	:	PUNCT
ffhd-1666	1	81	2160	2160	NUM
ffhd-1666	1	82	-	-	SYM
ffhd-1666	1	83	3855	3855	NUM
ffhd-1666	1	84	;	;	PUNCT
ffhd-1666	1	85	print	print	NOUN
ffhd-1666	1	86	issn	issn	PROPN
ffhd-1666	1	87	:	:	PUNCT
ffhd-1666	1	88	2378	2378	NUM
ffhd-1666	1	89	-	-	SYM
ffhd-1666	1	90	7007	7007	NUM
ffhd-1666	1	91	home	home	NOUN
ffhd-1666	1	92	food	food	NOUN
ffhd-1666	1	93	science	science	NOUN
ffhd-1666	1	94	publisher	publisher	NOUN
ffhd-1666	1	95	functional	functional	ADJ
ffhd-1666	1	96	food	food	NOUN
ffhd-1666	1	97	center	center	NOUN
ffhd-1666	1	98	current	current	ADJ
ffhd-1666	1	99	archives	archive	NOUN
ffhd-1666	1	100	about	about	ADP
ffhd-1666	1	101	about	about	ADP
ffhd-1666	1	102	the	the	DET
ffhd-1666	1	103	journal	journal	NOUN
ffhd-1666	1	104	aims	aim	VERB
ffhd-1666	1	105	and	and	CCONJ
ffhd-1666	1	106	scope	scope	NOUN
ffhd-1666	1	107	contact	contact	NOUN
ffhd-1666	1	108	editing	edit	VERB
ffhd-1666	1	109	services	service	NOUN
ffhd-1666	1	110	editorial	editorial	ADJ
ffhd-1666	1	111	team	team	NOUN
ffhd-1666	1	112	express	express	VERB
ffhd-1666	1	113	peer	peer	NOUN
ffhd-1666	1	114	review	review	NOUN
ffhd-1666	1	115	graphical	graphical	ADJ
ffhd-1666	1	116	abstract	abstract	ADJ
ffhd-1666	1	117	journal	journal	NOUN
ffhd-1666	1	118	insights	insight	VERB
ffhd-1666	1	119	privacy	privacy	NOUN
ffhd-1666	1	120	statement	statement	NOUN
ffhd-1666	1	121	submissions	submission	NOUN
ffhd-1666	1	122	announcements	announcement	NOUN
ffhd-1666	1	123	search	search	NOUN
ffhd-1666	1	124	search	search	NOUN
ffhd-1666	1	125	register	register	NOUN
ffhd-1666	1	126	login	login	NOUN
ffhd-1666	1	127	home	home	NOUN
ffhd-1666	1	128	/	/	SYM
ffhd-1666	1	129	archives	archive	NOUN
ffhd-1666	1	130	/	/	SYM
ffhd-1666	1	131	vol	vol	NOUN
ffhd-1666	1	132	.	.	PROPN
ffhd-1666	1	133	15	15	NUM
ffhd-1666	2	1	no	no	NOUN
ffhd-1666	2	2	.	.	NOUN
ffhd-1666	2	3	8	8	NUM
ffhd-1666	2	4	(	(	PUNCT
ffhd-1666	2	5	2025	2025	NUM
ffhd-1666	2	6	):	):	PUNCT
ffhd-1666	2	7	august	august	PROPN
ffhd-1666	2	8	2025	2025	NUM
ffhd-1666	2	9	/	/	SYM
ffhd-1666	2	10	research	research	NOUN
ffhd-1666	2	11	articles	article	NOUN
ffhd-1666	2	12	rice	rice	NOUN
ffhd-1666	2	13	-	-	PUNCT
ffhd-1666	2	14	derived	derive	VERB
ffhd-1666	2	15	glucosylceramides	glucosylceramide	NOUN
ffhd-1666	2	16	up	up	ADP
ffhd-1666	2	17	-	-	PUNCT
ffhd-1666	2	18	regulate	regulate	VERB
ffhd-1666	2	19	hla	hla	PROPN
ffhd-1666	2	20	-	-	PUNCT
ffhd-1666	2	21	dr	dr	NOUN
ffhd-1666	2	22	expression	expression	NOUN
ffhd-1666	2	23	on	on	ADP
ffhd-1666	2	24	myeloid	myeloid	ADJ
ffhd-1666	2	25	dendritic	dendritic	ADJ
ffhd-1666	2	26	cells	cell	NOUN
ffhd-1666	2	27	to	to	PART
ffhd-1666	2	28	activate	activate	VERB
ffhd-1666	2	29	innate	innate	ADJ
ffhd-1666	2	30	immune	immune	ADJ
ffhd-1666	2	31	responses	response	NOUN
ffhd-1666	2	32	in	in	ADP
ffhd-1666	2	33	healthy	healthy	ADJ
ffhd-1666	2	34	japanese	japanese	ADJ
ffhd-1666	2	35	subjects	subject	NOUN
ffhd-1666	2	36	:	:	PUNCT
ffhd-1666	2	37	a	a	DET
ffhd-1666	2	38	randomized	randomized	ADJ
ffhd-1666	2	39	,	,	PUNCT
ffhd-1666	2	40	placebo	placebo	NOUN
ffhd-1666	2	41	-	-	PUNCT
ffhd-1666	2	42	controlled	control	VERB
ffhd-1666	2	43	,	,	PUNCT
ffhd-1666	2	44	double	double	ADJ
ffhd-1666	2	45	-	-	PUNCT
ffhd-1666	2	46	blind	blind	ADJ
ffhd-1666	2	47	trial	trial	NOUN
ffhd-1666	2	48	authors	author	NOUN
ffhd-1666	2	49	kenchi	kenchi	PROPN
ffhd-1666	2	50	miyasaka	miyasaka	ADV
ffhd-1666	2	51	shogo	shogo	PROPN
ffhd-1666	2	52	takeda	takeda	PROPN
ffhd-1666	2	53	akari	akari	PROPN
ffhd-1666	2	54	yoneda	yoneda	PROPN
ffhd-1666	2	55	mizuki	mizuki	PROPN
ffhd-1666	2	56	kubo	kubo	PROPN
ffhd-1666	2	57	hiroshi	hiroshi	PROPN
ffhd-1666	2	58	shimoda	shimoda	PROPN
ffhd-1666	3	1	doi	doi	PROPN
ffhd-1666	3	2	:	:	PUNCT
ffhd-1666	3	3	https://doi.org/10.31989/ffhd.v15i8.1666	https://doi.org/10.31989/ffhd.v15i8.1666	VERB
ffhd-1666	3	4	abstract	abstract	ADJ
ffhd-1666	3	5	introduction	introduction	NOUN
ffhd-1666	3	6	:	:	PUNCT
ffhd-1666	3	7	in	in	ADP
ffhd-1666	3	8	a	a	DET
ffhd-1666	3	9	prior	prior	ADJ
ffhd-1666	3	10	study	study	NOUN
ffhd-1666	3	11	,	,	PUNCT
ffhd-1666	3	12	we	we	PRON
ffhd-1666	3	13	found	find	VERB
ffhd-1666	3	14	that	that	SCONJ
ffhd-1666	3	15	rice	rice	NOUN
ffhd-1666	3	16	-	-	PUNCT
ffhd-1666	3	17	derived	derive	VERB
ffhd-1666	3	18	glucosylceramides	glucosylceramide	NOUN
ffhd-1666	3	19	(	(	PUNCT
ffhd-1666	3	20	glcer	glcer	NOUN
ffhd-1666	3	21	)	)	PUNCT
ffhd-1666	3	22	improved	improve	VERB
ffhd-1666	3	23	overall	overall	ADJ
ffhd-1666	3	24	health	health	NOUN
ffhd-1666	3	25	and	and	CCONJ
ffhd-1666	3	26	alleviated	alleviate	VERB
ffhd-1666	3	27	common	common	ADJ
ffhd-1666	3	28	cold	cold	ADJ
ffhd-1666	3	29	symptoms	symptom	NOUN
ffhd-1666	3	30	,	,	PUNCT
ffhd-1666	3	31	including	include	VERB
ffhd-1666	3	32	nasal	nasal	PROPN
ffhd-1666	3	33	congestion	congestion	NOUN
ffhd-1666	3	34	,	,	PUNCT
ffhd-1666	3	35	sore	sore	ADJ
ffhd-1666	3	36	throat	throat	NOUN
ffhd-1666	3	37	,	,	PUNCT
ffhd-1666	3	38	coughing	coughing	NOUN
ffhd-1666	3	39	,	,	PUNCT
ffhd-1666	3	40	headache	headache	NOUN
ffhd-1666	3	41	,	,	PUNCT
ffhd-1666	3	42	muscle	muscle	NOUN
ffhd-1666	3	43	pain	pain	NOUN
ffhd-1666	3	44	,	,	PUNCT
ffhd-1666	3	45	and	and	CCONJ
ffhd-1666	3	46	diarrhea	diarrhea	NOUN
ffhd-1666	3	47	.	.	PUNCT
ffhd-1666	4	1	one	one	NUM
ffhd-1666	4	2	of	of	ADP
ffhd-1666	4	3	the	the	DET
ffhd-1666	4	4	underlying	underlying	ADJ
ffhd-1666	4	5	mechanisms	mechanism	NOUN
ffhd-1666	4	6	may	may	AUX
ffhd-1666	4	7	involve	involve	VERB
ffhd-1666	4	8	the	the	DET
ffhd-1666	4	9	enhanced	enhanced	ADJ
ffhd-1666	4	10	activation	activation	NOUN
ffhd-1666	4	11	of	of	ADP
ffhd-1666	4	12	antigen	antigen	NOUN
ffhd-1666	4	13	-	-	PUNCT
ffhd-1666	4	14	presenting	present	VERB
ffhd-1666	4	15	cells	cell	NOUN
ffhd-1666	4	16	(	(	PUNCT
ffhd-1666	4	17	apc	apc	PROPN
ffhd-1666	4	18	)	)	PUNCT
ffhd-1666	4	19	through	through	ADP
ffhd-1666	4	20	mincle	mincle	NOUN
ffhd-1666	4	21	,	,	PUNCT
ffhd-1666	4	22	a	a	DET
ffhd-1666	4	23	c	c	NOUN
ffhd-1666	4	24	-	-	PUNCT
ffhd-1666	4	25	type	type	NOUN
ffhd-1666	4	26	lectin	lectin	ADJ
ffhd-1666	4	27	receptor	receptor	NOUN
ffhd-1666	4	28	,	,	PUNCT
ffhd-1666	4	29	and	and	CCONJ
ffhd-1666	4	30	toll	toll	NOUN
ffhd-1666	4	31	-	-	PUNCT
ffhd-1666	4	32	like	like	ADJ
ffhd-1666	4	33	receptors	receptor	NOUN
ffhd-1666	4	34	.	.	PUNCT
ffhd-1666	5	1	however	however	ADV
ffhd-1666	5	2	,	,	PUNCT
ffhd-1666	5	3	the	the	DET
ffhd-1666	5	4	clinical	clinical	ADJ
ffhd-1666	5	5	impact	impact	NOUN
ffhd-1666	5	6	of	of	ADP
ffhd-1666	5	7	glcer	glcer	NOUN
ffhd-1666	5	8	on	on	ADP
ffhd-1666	5	9	cell	cell	NOUN
ffhd-1666	5	10	-	-	PUNCT
ffhd-1666	5	11	mediated	mediate	VERB
ffhd-1666	5	12	innate	innate	ADJ
ffhd-1666	5	13	immunity	immunity	NOUN
ffhd-1666	5	14	,	,	PUNCT
ffhd-1666	5	15	especially	especially	ADV
ffhd-1666	5	16	concerning	concern	VERB
ffhd-1666	5	17	apc	apc	PROPN
ffhd-1666	5	18	,	,	PUNCT
ffhd-1666	5	19	is	be	AUX
ffhd-1666	5	20	not	not	PART
ffhd-1666	5	21	yet	yet	ADV
ffhd-1666	5	22	fully	fully	ADV
ffhd-1666	5	23	understood	understand	VERB
ffhd-1666	5	24	.	.	PUNCT
ffhd-1666	5	25	  	  	SPACE
ffhd-1666	6	1	objective	objective	NOUN
ffhd-1666	6	2	:	:	PUNCT
ffhd-1666	6	3	therefore	therefore	ADV
ffhd-1666	6	4	,	,	PUNCT
ffhd-1666	6	5	we	we	PRON
ffhd-1666	6	6	performed	perform	VERB
ffhd-1666	6	7	a	a	DET
ffhd-1666	6	8	clinical	clinical	ADJ
ffhd-1666	6	9	study	study	NOUN
ffhd-1666	6	10	on	on	ADP
ffhd-1666	6	11	the	the	DET
ffhd-1666	6	12	effects	effect	NOUN
ffhd-1666	6	13	of	of	ADP
ffhd-1666	6	14	commercially	commercially	ADV
ffhd-1666	6	15	available	available	ADJ
ffhd-1666	6	16	rice	rice	NOUN
ffhd-1666	6	17	-	-	PUNCT
ffhd-1666	6	18	glcer	glcer	NOUN
ffhd-1666	6	19	(	(	PUNCT
ffhd-1666	6	20	oryza	oryza	PROPN
ffhd-1666	6	21	ceramide	ceramide	PROPN
ffhd-1666	6	22	®	®	PROPN
ffhd-1666	6	23	)	)	PUNCT
ffhd-1666	6	24	on	on	ADP
ffhd-1666	6	25	blood	blood	NOUN
ffhd-1666	6	26	dendritic	dendritic	ADJ
ffhd-1666	6	27	cells	cell	NOUN
ffhd-1666	6	28	(	(	PUNCT
ffhd-1666	6	29	dc	dc	PROPN
ffhd-1666	6	30	)	)	PUNCT
ffhd-1666	6	31	.	.	PUNCT
ffhd-1666	7	1	methods	method	NOUN
ffhd-1666	7	2	:	:	PUNCT
ffhd-1666	7	3	the	the	DET
ffhd-1666	7	4	study	study	NOUN
ffhd-1666	7	5	was	be	AUX
ffhd-1666	7	6	planned	plan	VERB
ffhd-1666	7	7	as	as	ADP
ffhd-1666	7	8	a	a	DET
ffhd-1666	7	9	randomized	randomized	ADJ
ffhd-1666	7	10	,	,	PUNCT
ffhd-1666	7	11	placebo	placebo	NOUN
ffhd-1666	7	12	-	-	PUNCT
ffhd-1666	7	13	controlled	control	VERB
ffhd-1666	7	14	,	,	PUNCT
ffhd-1666	7	15	double	double	ADJ
ffhd-1666	7	16	-	-	PUNCT
ffhd-1666	7	17	blind	blind	ADJ
ffhd-1666	7	18	trial	trial	NOUN
ffhd-1666	7	19	.	.	PUNCT
ffhd-1666	8	1	oryza	oryza	PROPN
ffhd-1666	8	2	ceramide	ceramide	PROPN
ffhd-1666	8	3	®	®	PROPN
ffhd-1666	8	4	-pcd	-pcd	X
ffhd-1666	8	5	(	(	PUNCT
ffhd-1666	8	6	oc	oc	NOUN
ffhd-1666	8	7	-	-	NOUN
ffhd-1666	8	8	pcd	pcd	NOUN
ffhd-1666	8	9	,	,	PUNCT
ffhd-1666	8	10	20	20	NUM
ffhd-1666	8	11	mg	mg	NOUN
ffhd-1666	8	12	)	)	PUNCT
ffhd-1666	8	13	tablets	tablet	NOUN
ffhd-1666	8	14	,	,	PUNCT
ffhd-1666	8	15	each	each	PRON
ffhd-1666	8	16	containing	contain	VERB
ffhd-1666	8	17	0.6	0.6	NUM
ffhd-1666	8	18	mg	mg	NOUN
ffhd-1666	8	19	of	of	ADP
ffhd-1666	8	20	glcer	glcer	NOUN
ffhd-1666	8	21	,	,	PUNCT
ffhd-1666	8	22	were	be	AUX
ffhd-1666	8	23	used	use	VERB
ffhd-1666	8	24	as	as	ADP
ffhd-1666	8	25	the	the	DET
ffhd-1666	8	26	active	active	ADJ
ffhd-1666	8	27	tablet	tablet	NOUN
ffhd-1666	8	28	.	.	PUNCT
ffhd-1666	9	1	twenty	twenty	NUM
ffhd-1666	9	2	-	-	PUNCT
ffhd-1666	9	3	two	two	NUM
ffhd-1666	9	4	healthy	healthy	ADJ
ffhd-1666	9	5	japanese	japanese	ADJ
ffhd-1666	9	6	individuals	individual	NOUN
ffhd-1666	9	7	were	be	AUX
ffhd-1666	9	8	enrolled	enrol	VERB
ffhd-1666	9	9	and	and	CCONJ
ffhd-1666	9	10	randomly	randomly	ADV
ffhd-1666	9	11	divided	divide	VERB
ffhd-1666	9	12	to	to	ADP
ffhd-1666	9	13	an	an	DET
ffhd-1666	9	14	active	active	ADJ
ffhd-1666	9	15	group	group	NOUN
ffhd-1666	9	16	(	(	PUNCT
ffhd-1666	9	17	n=11	n=11	NOUN
ffhd-1666	9	18	)	)	PUNCT
ffhd-1666	9	19	or	or	CCONJ
ffhd-1666	9	20	placebo	placebo	NOUN
ffhd-1666	9	21	group	group	NOUN
ffhd-1666	9	22	(	(	PUNCT
ffhd-1666	9	23	n=11	n=11	NOUN
ffhd-1666	9	24	for	for	ADP
ffhd-1666	9	25	8	8	NUM
ffhd-1666	9	26	weeks	week	NOUN
ffhd-1666	9	27	,	,	PUNCT
ffhd-1666	9	28	participants	participant	NOUN
ffhd-1666	9	29	took	take	VERB
ffhd-1666	9	30	three	three	NUM
ffhd-1666	9	31	active	active	ADJ
ffhd-1666	9	32	tablets	tablet	NOUN
ffhd-1666	9	33	(	(	PUNCT
ffhd-1666	9	34	60	60	NUM
ffhd-1666	9	35	mg	mg	NOUN
ffhd-1666	9	36	of	of	ADP
ffhd-1666	9	37	oc	oc	NOUN
ffhd-1666	9	38	-	-	NOUN
ffhd-1666	9	39	pcd	pcd	NOUN
ffhd-1666	9	40	)	)	PUNCT
ffhd-1666	9	41	or	or	CCONJ
ffhd-1666	9	42	three	three	NUM
ffhd-1666	9	43	placebo	placebo	NOUN
ffhd-1666	9	44	tablets	tablet	NOUN
ffhd-1666	9	45	daily	daily	ADV
ffhd-1666	9	46	.	.	PUNCT
ffhd-1666	10	1	dc	dc	PROPN
ffhd-1666	10	2	ratios	ratio	NOUN
ffhd-1666	10	3	and	and	CCONJ
ffhd-1666	10	4	cd	cd	NOUN
ffhd-1666	10	5	expression	expression	NOUN
ffhd-1666	10	6	on	on	ADP
ffhd-1666	10	7	dc	dc	PROPN
ffhd-1666	10	8	during	during	ADP
ffhd-1666	10	9	the	the	DET
ffhd-1666	10	10	intervention	intervention	NOUN
ffhd-1666	10	11	were	be	AUX
ffhd-1666	10	12	set	set	VERB
ffhd-1666	10	13	as	as	ADP
ffhd-1666	10	14	the	the	DET
ffhd-1666	10	15	primary	primary	ADJ
ffhd-1666	10	16	outcomes	outcome	NOUN
ffhd-1666	10	17	.	.	PUNCT
ffhd-1666	10	18	  	  	SPACE
ffhd-1666	11	1	results	result	NOUN
ffhd-1666	11	2	:	:	PUNCT
ffhd-1666	11	3	all	all	DET
ffhd-1666	11	4	subjects	subject	NOUN
ffhd-1666	11	5	finished	finish	VERB
ffhd-1666	11	6	the	the	DET
ffhd-1666	11	7	trial	trial	NOUN
ffhd-1666	11	8	,	,	PUNCT
ffhd-1666	11	9	and	and	CCONJ
ffhd-1666	11	10	the	the	DET
ffhd-1666	11	11	per	per	ADP
ffhd-1666	11	12	protocol	protocol	NOUN
ffhd-1666	11	13	set	set	NOUN
ffhd-1666	11	14	constituted	constitute	VERB
ffhd-1666	11	15	11	11	NUM
ffhd-1666	11	16	in	in	ADP
ffhd-1666	11	17	each	each	DET
ffhd-1666	11	18	group	group	NOUN
ffhd-1666	11	19	.	.	PUNCT
ffhd-1666	12	1	the	the	DET
ffhd-1666	12	2	myeloid	myeloid	PROPN
ffhd-1666	12	3	dc	dc	PROPN
ffhd-1666	12	4	(	(	PUNCT
ffhd-1666	12	5	mdc	mdc	NOUN
ffhd-1666	12	6	)	)	PUNCT
ffhd-1666	12	7	ratio	ratio	NOUN
ffhd-1666	12	8	and	and	CCONJ
ffhd-1666	12	9	cd86	cd86	PROPN
ffhd-1666	12	10	expression	expression	NOUN
ffhd-1666	12	11	were	be	AUX
ffhd-1666	12	12	significantly	significantly	ADV
ffhd-1666	12	13	lower	low	ADJ
ffhd-1666	12	14	in	in	ADP
ffhd-1666	12	15	the	the	DET
ffhd-1666	12	16	active	active	ADJ
ffhd-1666	12	17	group	group	NOUN
ffhd-1666	12	18	than	than	ADP
ffhd-1666	12	19	in	in	ADP
ffhd-1666	12	20	the	the	DET
ffhd-1666	12	21	placebo	placebo	NOUN
ffhd-1666	12	22	group	group	NOUN
ffhd-1666	12	23	.	.	PUNCT
ffhd-1666	13	1	in	in	ADP
ffhd-1666	13	2	contrast	contrast	NOUN
ffhd-1666	13	3	,	,	PUNCT
ffhd-1666	13	4	hla	hla	PROPN
ffhd-1666	13	5	-	-	PUNCT
ffhd-1666	13	6	dr	dr	PROPN
ffhd-1666	13	7	expression	expression	NOUN
ffhd-1666	13	8	on	on	ADP
ffhd-1666	13	9	mdc	mdc	NOUN
ffhd-1666	13	10	was	be	AUX
ffhd-1666	13	11	slightly	slightly	ADV
ffhd-1666	13	12	higher	high	ADJ
ffhd-1666	13	13	in	in	ADP
ffhd-1666	13	14	the	the	DET
ffhd-1666	13	15	active	active	ADJ
ffhd-1666	13	16	group	group	NOUN
ffhd-1666	13	17	.	.	PUNCT
ffhd-1666	14	1	a	a	DET
ffhd-1666	14	2	stratified	stratified	ADJ
ffhd-1666	14	3	analysis	analysis	NOUN
ffhd-1666	14	4	of	of	ADP
ffhd-1666	14	5	subjects	subject	NOUN
ffhd-1666	14	6	with	with	ADP
ffhd-1666	14	7	mean	mean	ADJ
ffhd-1666	14	8	fluorescence	fluorescence	NOUN
ffhd-1666	14	9	intensity	intensity	NOUN
ffhd-1666	14	10	(	(	PUNCT
ffhd-1666	14	11	mfi	mfi	PROPN
ffhd-1666	14	12	)	)	PUNCT
ffhd-1666	14	13	for	for	ADP
ffhd-1666	14	14	hla	hla	PROPN
ffhd-1666	14	15	-	-	PUNCT
ffhd-1666	14	16	dr	dr	PROPN
ffhd-1666	14	17	<	<	PROPN
ffhd-1666	14	18	60,000	60,000	NUM
ffhd-1666	14	19	revealed	reveal	VERB
ffhd-1666	14	20	a	a	DET
ffhd-1666	14	21	significant	significant	ADJ
ffhd-1666	14	22	high	high	ADJ
ffhd-1666	14	23	value	value	NOUN
ffhd-1666	14	24	in	in	ADP
ffhd-1666	14	25	hla	hla	PROPN
ffhd-1666	14	26	-	-	PUNCT
ffhd-1666	14	27	dr	dr	PROPN
ffhd-1666	14	28	expression	expression	NOUN
ffhd-1666	14	29	in	in	ADP
ffhd-1666	14	30	the	the	DET
ffhd-1666	14	31	active	active	ADJ
ffhd-1666	14	32	group	group	NOUN
ffhd-1666	14	33	.	.	PUNCT
ffhd-1666	15	1	a	a	DET
ffhd-1666	15	2	correlation	correlation	NOUN
ffhd-1666	15	3	was	be	AUX
ffhd-1666	15	4	observed	observe	VERB
ffhd-1666	15	5	between	between	ADP
ffhd-1666	15	6	changes	change	NOUN
ffhd-1666	15	7	in	in	ADP
ffhd-1666	15	8	mfi	mfi	PROPN
ffhd-1666	15	9	values	value	NOUN
ffhd-1666	15	10	for	for	ADP
ffhd-1666	15	11	hla	hla	PROPN
ffhd-1666	15	12	-	-	PUNCT
ffhd-1666	15	13	dr	dr	PROPN
ffhd-1666	15	14	and	and	CCONJ
ffhd-1666	15	15	cd86	cd86	PROPN
ffhd-1666	15	16	on	on	ADP
ffhd-1666	15	17	mdc	mdc	PROPN
ffhd-1666	15	18	.	.	PUNCT
ffhd-1666	16	1	however	however	ADV
ffhd-1666	16	2	,	,	PUNCT
ffhd-1666	16	3	plasmacytoid	plasmacytoid	PROPN
ffhd-1666	16	4	dc	dc	PROPN
ffhd-1666	16	5	parameters	parameter	NOUN
ffhd-1666	16	6	did	do	AUX
ffhd-1666	16	7	not	not	PART
ffhd-1666	16	8	change	change	VERB
ffhd-1666	16	9	.	.	PUNCT
ffhd-1666	16	10	  	  	SPACE
ffhd-1666	16	11	novelty	novelty	NOUN
ffhd-1666	16	12	of	of	ADP
ffhd-1666	16	13	the	the	DET
ffhd-1666	16	14	study	study	NOUN
ffhd-1666	16	15	:	:	PUNCT
ffhd-1666	16	16	rice	rice	NOUN
ffhd-1666	16	17	-	-	PUNCT
ffhd-1666	16	18	derived	derive	VERB
ffhd-1666	16	19	glcer	glcer	NOUN
ffhd-1666	16	20	was	be	AUX
ffhd-1666	16	21	firstly	firstly	ADV
ffhd-1666	16	22	clarified	clarify	VERB
ffhd-1666	16	23	to	to	PART
ffhd-1666	16	24	enhance	enhance	VERB
ffhd-1666	16	25	innate	innate	ADJ
ffhd-1666	16	26	immune	immune	ADJ
ffhd-1666	16	27	response	response	NOUN
ffhd-1666	16	28	specifically	specifically	ADV
ffhd-1666	16	29	mdc	mdc	VERB
ffhd-1666	16	30	to	to	PART
ffhd-1666	16	31	improve	improve	VERB
ffhd-1666	16	32	common	common	ADJ
ffhd-1666	16	33	cold	cold	ADJ
ffhd-1666	16	34	symptoms	symptom	NOUN
ffhd-1666	16	35	through	through	ADP
ffhd-1666	16	36	this	this	DET
ffhd-1666	16	37	clinical	clinical	ADJ
ffhd-1666	16	38	trial	trial	NOUN
ffhd-1666	16	39	.	.	PUNCT
ffhd-1666	17	1	conclusions	conclusion	NOUN
ffhd-1666	17	2	:	:	PUNCT
ffhd-1666	17	3	the	the	DET
ffhd-1666	17	4	oral	oral	ADJ
ffhd-1666	17	5	administration	administration	NOUN
ffhd-1666	17	6	of	of	ADP
ffhd-1666	17	7	glcer	glcer	PROPN
ffhd-1666	17	8	affected	affect	VERB
ffhd-1666	17	9	mdc	mdc	NOUN
ffhd-1666	17	10	by	by	ADP
ffhd-1666	17	11	up	up	ADV
ffhd-1666	17	12	-	-	PUNCT
ffhd-1666	17	13	regulating	regulate	VERB
ffhd-1666	17	14	the	the	DET
ffhd-1666	17	15	expression	expression	NOUN
ffhd-1666	17	16	of	of	ADP
ffhd-1666	17	17	hla	hla	PROPN
ffhd-1666	17	18	-	-	PUNCT
ffhd-1666	17	19	dr	dr	PROPN
ffhd-1666	17	20	and	and	CCONJ
ffhd-1666	17	21	down	down	ADV
ffhd-1666	17	22	-	-	PUNCT
ffhd-1666	17	23	regulating	regulate	VERB
ffhd-1666	17	24	cd86	cd86	PROPN
ffhd-1666	17	25	,	,	PUNCT
ffhd-1666	17	26	which	which	PRON
ffhd-1666	17	27	contribute	contribute	VERB
ffhd-1666	17	28	to	to	ADP
ffhd-1666	17	29	antigen	antigen	ADJ
ffhd-1666	17	30	presentation	presentation	NOUN
ffhd-1666	17	31	to	to	ADP
ffhd-1666	17	32	t	t	PROPN
ffhd-1666	17	33	lymphocytes	lymphocyte	NOUN
ffhd-1666	17	34	.	.	PUNCT
ffhd-1666	18	1	the	the	DET
ffhd-1666	18	2	present	present	ADJ
ffhd-1666	18	3	results	result	NOUN
ffhd-1666	18	4	suggests	suggest	VERB
ffhd-1666	18	5	that	that	SCONJ
ffhd-1666	18	6	glcer	glcer	NOUN
ffhd-1666	18	7	attenuate	attenuate	VERB
ffhd-1666	18	8	cold	cold	ADJ
ffhd-1666	18	9	symptoms	symptom	NOUN
ffhd-1666	18	10	by	by	ADP
ffhd-1666	18	11	enhancing	enhance	VERB
ffhd-1666	18	12	the	the	DET
ffhd-1666	18	13	interaction	interaction	NOUN
ffhd-1666	18	14	between	between	ADP
ffhd-1666	18	15	mdc	mdc	NOUN
ffhd-1666	18	16	and	and	CCONJ
ffhd-1666	18	17	t	t	NOUN
ffhd-1666	18	18	lymphocytes	lymphocyte	NOUN
ffhd-1666	18	19	.	.	PUNCT
ffhd-1666	19	1	trial	trial	NOUN
ffhd-1666	19	2	registration	registration	NOUN
ffhd-1666	19	3	:	:	PUNCT
ffhd-1666	19	4	umin	umin	PROPN
ffhd-1666	19	5	-	-	PUNCT
ffhd-1666	19	6	ctr	ctr	PROPN
ffhd-1666	19	7	:	:	PUNCT
ffhd-1666	19	8	umin000055299	umin000055299	NOUN
ffhd-1666	19	9	keywords	keyword	NOUN
ffhd-1666	19	10	:	:	PUNCT
ffhd-1666	19	11	rice	rice	NOUN
ffhd-1666	19	12	;	;	PUNCT
ffhd-1666	19	13	glucosylceramide	glucosylceramide	NOUN
ffhd-1666	19	14	;	;	PUNCT
ffhd-1666	19	15	hla	hla	PROPN
ffhd-1666	19	16	-	-	PUNCT
ffhd-1666	19	17	dr	dr	PROPN
ffhd-1666	19	18	;	;	PUNCT
ffhd-1666	19	19	dendritic	dendritic	ADJ
ffhd-1666	19	20	cells	cell	NOUN
ffhd-1666	19	21	;	;	PUNCT
ffhd-1666	20	1	cd86	cd86	PROPN
ffhd-1666	20	2	downloads	download	VERB
ffhd-1666	20	3	[	[	X
ffhd-1666	20	4	abstract	abstract	X
ffhd-1666	20	5	]	]	X
ffhd-1666	21	1	[	[	X
ffhd-1666	21	2	full	full	ADJ
ffhd-1666	21	3	article	article	NOUN
ffhd-1666	21	4	]	]	PUNCT
ffhd-1666	21	5	published	publish	VERB
ffhd-1666	21	6	2025	2025	NUM
ffhd-1666	21	7	-	-	SYM
ffhd-1666	21	8	08	08	NUM
ffhd-1666	21	9	-	-	PUNCT
ffhd-1666	21	10	04	04	NUM
ffhd-1666	21	11	issue	issue	NOUN
ffhd-1666	21	12	vol	vol	NOUN
ffhd-1666	21	13	.	.	PROPN
ffhd-1666	21	14	15	15	NUM
ffhd-1666	22	1	no	no	NOUN
ffhd-1666	22	2	.	.	NOUN
ffhd-1666	22	3	8	8	NUM
ffhd-1666	22	4	(	(	PUNCT
ffhd-1666	22	5	2025	2025	NUM
ffhd-1666	22	6	):	):	PUNCT
ffhd-1666	22	7	august	august	PROPN
ffhd-1666	22	8	2025	2025	NUM
ffhd-1666	22	9	section	section	NOUN
ffhd-1666	22	10	research	research	NOUN
ffhd-1666	22	11	articles	article	NOUN
ffhd-1666	22	12	license	license	VERB
ffhd-1666	22	13	copyright	copyright	NOUN
ffhd-1666	22	14	(	(	PUNCT
ffhd-1666	22	15	c	c	NOUN
ffhd-1666	22	16	)	)	PUNCT
ffhd-1666	22	17	2025	2025	NUM
ffhd-1666	22	18	functional	functional	ADJ
ffhd-1666	22	19	foods	food	NOUN
ffhd-1666	22	20	in	in	ADP
ffhd-1666	22	21	health	health	NOUN
ffhd-1666	22	22	and	and	CCONJ
ffhd-1666	22	23	disease	disease	PROPN
ffhd-1666	22	24	online	online	PROPN
ffhd-1666	22	25	issn	issn	PROPN
ffhd-1666	22	26	:	:	PUNCT
ffhd-1666	22	27	2160	2160	NUM
ffhd-1666	22	28	-	-	SYM
ffhd-1666	22	29	3855	3855	NUM
ffhd-1666	22	30	;	;	PUNCT
ffhd-1666	22	31	print	print	NOUN
ffhd-1666	22	32	issn	issn	PROPN
ffhd-1666	22	33	:	:	PUNCT
ffhd-1666	22	34	2378	2378	NUM
ffhd-1666	22	35	-	-	SYM
ffhd-1666	22	36	7007	7007	NUM
ffhd-1666	22	37	this	this	DET
ffhd-1666	22	38	work	work	NOUN
ffhd-1666	22	39	is	be	AUX
ffhd-1666	22	40	licensed	license	VERB
ffhd-1666	22	41	under	under	ADP
ffhd-1666	22	42	a	a	DET
ffhd-1666	22	43	creative	creative	ADJ
ffhd-1666	22	44	commons	common	NOUN
ffhd-1666	22	45	attribution	attribution	NOUN
ffhd-1666	22	46	-	-	PUNCT
ffhd-1666	22	47	noncommercial	noncommercial	ADJ
ffhd-1666	22	48	4.0	4.0	NUM
ffhd-1666	22	49	international	international	ADJ
ffhd-1666	22	50	license	license	NOUN
ffhd-1666	22	51	.	.	PUNCT
ffhd-1666	23	1	authors	author	NOUN
ffhd-1666	23	2	retain	retain	VERB
ffhd-1666	23	3	the	the	DET
ffhd-1666	23	4	copyright	copyright	NOUN
ffhd-1666	23	5	of	of	ADP
ffhd-1666	23	6	their	their	PRON
ffhd-1666	23	7	articles	article	NOUN
ffhd-1666	23	8	and	and	CCONJ
ffhd-1666	23	9	grant	grant	VERB
ffhd-1666	23	10	the	the	DET
ffhd-1666	23	11	functional	functional	ADJ
ffhd-1666	23	12	food	food	NOUN
ffhd-1666	23	13	center	center	NOUN
ffhd-1666	23	14	(	(	PUNCT
ffhd-1666	23	15	ffc	ffc	NOUN
ffhd-1666	23	16	)	)	PUNCT
ffhd-1666	23	17	and	and	CCONJ
ffhd-1666	23	18	its	its	PRON
ffhd-1666	23	19	journals	journal	NOUN
ffhd-1666	23	20	the	the	DET
ffhd-1666	23	21	right	right	NOUN
ffhd-1666	23	22	of	of	ADP
ffhd-1666	23	23	first	first	ADJ
ffhd-1666	23	24	publication	publication	NOUN
ffhd-1666	23	25	under	under	ADP
ffhd-1666	23	26	the	the	DET
ffhd-1666	23	27	terms	term	NOUN
ffhd-1666	23	28	of	of	ADP
ffhd-1666	23	29	the	the	DET
ffhd-1666	23	30	creative	creative	ADJ
ffhd-1666	23	31	commons	common	NOUN
ffhd-1666	23	32	attribution	attribution	NOUN
ffhd-1666	23	33	4.0	4.0	NUM
ffhd-1666	23	34	international	international	ADJ
ffhd-1666	23	35	license	license	NOUN
ffhd-1666	23	36	.	.	PUNCT
ffhd-1666	24	1	this	this	DET
ffhd-1666	24	2	license	license	NOUN
ffhd-1666	24	3	permits	permit	VERB
ffhd-1666	24	4	unrestricted	unrestricted	ADJ
ffhd-1666	24	5	use	use	NOUN
ffhd-1666	24	6	,	,	PUNCT
ffhd-1666	24	7	distribution	distribution	NOUN
ffhd-1666	24	8	,	,	PUNCT
ffhd-1666	24	9	and	and	CCONJ
ffhd-1666	24	10	reproduction	reproduction	NOUN
ffhd-1666	24	11	in	in	ADP
ffhd-1666	24	12	any	any	DET
ffhd-1666	24	13	medium	medium	NOUN
ffhd-1666	24	14	,	,	PUNCT
ffhd-1666	24	15	including	include	VERB
ffhd-1666	24	16	commercial	commercial	ADJ
ffhd-1666	24	17	use	use	NOUN
ffhd-1666	24	18	,	,	PUNCT
ffhd-1666	24	19	provided	provide	VERB
ffhd-1666	24	20	the	the	DET
ffhd-1666	24	21	original	original	ADJ
ffhd-1666	24	22	author(s	author(s	NOUN
ffhd-1666	24	23	)	)	PUNCT
ffhd-1666	24	24	and	and	CCONJ
ffhd-1666	24	25	source	source	NOUN
ffhd-1666	24	26	are	be	AUX
ffhd-1666	24	27	properly	properly	ADV
ffhd-1666	24	28	credited	credit	VERB
ffhd-1666	24	29	.	.	PUNCT
ffhd-1666	25	1	authors	author	NOUN
ffhd-1666	25	2	may	may	AUX
ffhd-1666	25	3	post	post	VERB
ffhd-1666	25	4	and	and	CCONJ
ffhd-1666	25	5	share	share	VERB
ffhd-1666	25	6	their	their	PRON
ffhd-1666	25	7	published	publish	VERB
ffhd-1666	25	8	work	work	NOUN
ffhd-1666	25	9	freely	freely	ADV
ffhd-1666	25	10	,	,	PUNCT
ffhd-1666	25	11	provided	provide	VERB
ffhd-1666	25	12	that	that	SCONJ
ffhd-1666	25	13	the	the	DET
ffhd-1666	25	14	original	original	ADJ
ffhd-1666	25	15	publication	publication	NOUN
ffhd-1666	25	16	in	in	ADP
ffhd-1666	25	17	this	this	DET
ffhd-1666	25	18	journal	journal	NOUN
ffhd-1666	25	19	is	be	AUX
ffhd-1666	25	20	acknowledged	acknowledge	VERB
ffhd-1666	25	21	.	.	PUNCT
ffhd-1666	26	1	by	by	ADP
ffhd-1666	26	2	submitting	submit	VERB
ffhd-1666	26	3	to	to	ADP
ffhd-1666	26	4	this	this	DET
ffhd-1666	26	5	journal	journal	NOUN
ffhd-1666	26	6	,	,	PUNCT
ffhd-1666	26	7	authors	author	NOUN
ffhd-1666	26	8	confirm	confirm	VERB
ffhd-1666	26	9	that	that	SCONJ
ffhd-1666	26	10	their	their	PRON
ffhd-1666	26	11	manuscripts	manuscript	NOUN
ffhd-1666	26	12	are	be	AUX
ffhd-1666	26	13	original	original	ADJ
ffhd-1666	26	14	,	,	PUNCT
ffhd-1666	26	15	not	not	PART
ffhd-1666	26	16	under	under	ADP
ffhd-1666	26	17	consideration	consideration	NOUN
ffhd-1666	26	18	elsewhere	elsewhere	ADV
ffhd-1666	26	19	,	,	PUNCT
ffhd-1666	26	20	and	and	CCONJ
ffhd-1666	26	21	that	that	SCONJ
ffhd-1666	26	22	they	they	PRON
ffhd-1666	26	23	hold	hold	VERB
ffhd-1666	26	24	the	the	DET
ffhd-1666	26	25	necessary	necessary	ADJ
ffhd-1666	26	26	rights	right	NOUN
ffhd-1666	26	27	to	to	PART
ffhd-1666	26	28	grant	grant	VERB
ffhd-1666	26	29	this	this	DET
ffhd-1666	26	30	license	license	NOUN
ffhd-1666	26	31	.	.	PUNCT
ffhd-1666	27	1	the	the	DET
ffhd-1666	27	2	functional	functional	ADJ
ffhd-1666	27	3	food	food	NOUN
ffhd-1666	27	4	center	center	NOUN
ffhd-1666	27	5	encourages	encourage	VERB
ffhd-1666	27	6	open	open	ADJ
ffhd-1666	27	7	scientific	scientific	ADJ
ffhd-1666	27	8	exchange	exchange	NOUN
ffhd-1666	27	9	and	and	CCONJ
ffhd-1666	27	10	allows	allow	VERB
ffhd-1666	27	11	derivative	derivative	ADJ
ffhd-1666	27	12	and	and	CCONJ
ffhd-1666	27	13	extended	extended	ADJ
ffhd-1666	27	14	works	work	NOUN
ffhd-1666	27	15	,	,	PUNCT
ffhd-1666	27	16	provided	provide	VERB
ffhd-1666	27	17	attribution	attribution	NOUN
ffhd-1666	27	18	to	to	ADP
ffhd-1666	27	19	the	the	DET
ffhd-1666	27	20	original	original	ADJ
ffhd-1666	27	21	publication	publication	NOUN
ffhd-1666	27	22	is	be	AUX
ffhd-1666	27	23	maintained	maintain	VERB
ffhd-1666	27	24	.	.	PUNCT
ffhd-1666	28	1	about	about	ADP
ffhd-1666	28	2	the	the	DET
ffhd-1666	28	3	journal	journal	NOUN
ffhd-1666	28	4	     	     	SPACE
ffhd-1666	28	5	editing	edit	VERB
ffhd-1666	28	6	services	service	NOUN
ffhd-1666	28	7	      	      	SPACE
ffhd-1666	28	8	graphical	graphical	ADJ
ffhd-1666	28	9	abstract	abstract	ADJ
ffhd-1666	28	10	     	     	SPACE
ffhd-1666	28	11	journal	journal	NOUN
ffhd-1666	28	12	insights	insight	NOUN
ffhd-1666	28	13	        	        	SPACE
ffhd-1666	28	14	submissions	submission	NOUN
ffhd-1666	28	15	        	        	SPACE
ffhd-1666	28	16	editorial	editorial	ADJ
ffhd-1666	28	17	team	team	NOUN
ffhd-1666	28	18	       	       	SPACE
ffhd-1666	28	19	privacy	privacy	NOUN
ffhd-1666	28	20	statement	statement	NOUN
ffhd-1666	28	21	        	        	SPACE
ffhd-1666	28	22	contact	contact	NOUN
ffhd-1666	28	23	        	        	SPACE
ffhd-1666	28	24	current	current	ADJ
ffhd-1666	28	25	        	        	SPACE
ffhd-1666	28	26	archives	archive	NOUN
ffhd-1666	28	27	  	  	SPACE
ffhd-1666	28	28	open	open	ADJ
ffhd-1666	28	29	journal	journal	NOUN
ffhd-1666	28	30	systems	system	NOUN
ffhd-1666	28	31	hosting	host	VERB
ffhd-1666	28	32	and	and	CCONJ
ffhd-1666	28	33	support	support	NOUN
ffhd-1666	28	34	by	by	ADP
ffhd-1666	28	35	:	:	PUNCT
ffhd-1666	28	36	openjournalsystems.com	openjournalsystems.com	X